Ivacaftor (benzenesulfonate) Size:Solid 2 mg InChi: InChI=1S/C7H15NO3/c1-8(2

InChi: InChI=1S/C7H15NO3/c1-8(2

InChi: InChI=1S/C21H28O2/c1-4-21(23)12-9-18-16-6-5-14-13-15(22)7-10-19(14

Solubility: DMSO: ≥ 46 mg/mL

Kinetics experiments revealed that PF-03716556 has a competitive and reversible mode of action

Formula: C19H32N2O5

Ivacaftor (benzenesulfonate) Size:Solid 2 mg InChi: InChI=1S/C7H15NO3/c1-8(2VX 770, is a drug used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, who account for 45% cases of cystic fibrosis, and is included in a combination drug, lumacaftor ivacaftor, which is used to treat people with cystic fibrosis who have the F508del mutation in CFTR. Ivacaftor is a "potentiator" of CFTR, meaning it increases the probability that the defective channel